Publications
5803 Results
- Journal / Conference
- Genome Med. 2025 May 12;17(1):53. doi: 10.1186/s13073-025-01468-y
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID40355948
- PMC
- PMC12070537
Patient rights in precision oncology: right treatment, right time, right dose, right order, right place
- Journal / Conference
- J Clin Oncol. 2025 Oct 10;43(29):3184-3197. doi: 10.1200/JCO-25-01003. Epub 2025 Sep 4.
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID40906970
- PMC
- PMC12509457
- Study Number(s)
- CTSU/C80405
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials
- Journal / Conference
- JCO Precis Oncol. 2025 Feb;9:e2400451. doi: 10.1200/PO-24-00451. Epub 2025 Feb 6.NIHMS2058197
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID39913886
- PMC
- PMC12002398
- Study Number(s)
- CTSU/EAY131
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H
- Journal / Conference
- Clin Cancer Res. 2025 Oct 15;31(20):4299-4310. doi: 10.1158/1078-0432.CCR-24-3531.NIHMS2084882
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID40388547
- PMC
- PMC12383705
- Study Number(s)
- CTSU/EAY131
Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131)
- Journal / Conference
- J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):42-48. doi: 10.1093/jncimonographs/lgae049
- Year
- 2025
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID39989037
- PMC
- PMC11848039
- Study Number(s)
- CTSU/EA1151
Design considerations and challenges in the CHinA National CancEr Screening (CHANCES) trial and Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
- Journal / Conference
- Nature Cancer. 2025 Jul;6(7):1242-1262. doi: 10.1038/s43018-025-00987-2. Epub 2025 Jun 27.NIHMS2100933
- Year
- 2025
- Research Committee(s)
- Leukemia
- PMID
- PMID40579588
- PMC
- PMC12377259
Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features
- Journal / Conference
- J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):10-13. doi: 10.1093/jncimonographs/lgae050
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989036
- PMC
- PMC11848033
The fundamentals of multiplicity adjustment in biostatistics
- Journal / Conference
- Trends Cancer. 2025 Aug;11(8):726-735. doi: 10.1016/j.trecan.2025.04.015. Epub 2025 Jun 5.NIHMS2077750
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID40480903
- PMC
- PMC12350067
Ag(e)nostic precision oncology therapy approvals across the years
- Journal / Conference
- J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):35-41. doi: 10.1093/jncimonographs/lgae043
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989041
- PMC
- PMC11848040
Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally
- Journal / Conference
- Cancer Lett. 2025 Jul 10;622:217681. doi: 10.1016/j.canlet.2025.217681. Epub 2025 Apr 8.NIHMS2077640
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID40209851
- PMC
- PMC12132789